SynthesisChina CDC weekly2020
China CDC in Action - Hypertension Prevention and Control.
Synthesis in China CDC weekly, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Community-integrated noncommunicable disease service models: lessons from China.Journal of global health · 2025Pooled it
- Cardiovascular Health Promotion and Disease Prevention in China: Calling for New-Era Strategies.JACC. Asia · 2026Review
- Impact of Adverse Metabolic Factors on the Burden of Chronic Kidney Disease in the Chinese Population ≥ 20 Years Old, 1990-2019.Diabetes/metabolism research and reviews · 2026Article
- Applying the SFIC synergistic governance model to analyze determinants of multisectoral collaborative chronic disease management in Beijing's district H.Scientific reports · 2025Article
- Dietary Pattern of Garlic and Risk of Chronic Diseases: Evidence From Three Large-Scale Cohorts.Health care science · 2025Article
- Practice and Effect Evaluation of Hypertension Homogenization Management Model Under the "Walking Hospital" Mode in Primary Medical Institutions.International journal of general medicine · 2025Article
- Improvement of Care Cascade for Hypertension and Diabetes in Rural China: Protocol for an Implementation Study.Journal of clinical hypertension (Greenwich, Conn.) · 2024Article
- Association of changes and cumulative measures of triglyceride-glucose index-body mass index with hypertension risk: a prospective cohort study.BMC public health · 2024Article
- Hypertension in China: epidemiology and treatment initiatives.Nature reviews. Cardiology · 2023Review
- Impact of health literacy and social support on medication adherence in patients with hypertension: a cross-sectional community-based study.BMC cardiovascular disorders · 2023Article
- Role of the cGAS-STING Pathway in Aging-related Endothelial Dysfunction.Aging and disease · 2022Article
- The Association of Midday Napping With Hypertension Among Chinese Adults Older Than 45 Years: Cross-sectional Study.JMIR public health and surveillance · 2022Article
- Epidemiological status quo of hypertension in elderly population in Changchun, China: a cross-sectional study.BMJ open · 2022Article
- A Call to Improve a Chain of Cardiovascular Disease Care.International journal of public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension contributes to a quarter of all-cause mortality in China. The Chinese government has put forward aims to control and prevent hypertension, and China CDC and other professional public health institutions have carried out a series of related efforts including the promotion of related policies and legislation, the improvement of modifiable risk factors of hypertension in the population, and promoting the National Primary Public Health Services to discover and manage patients with hypertension. China CDC has conducted multiple hypertension-related campaigns such as advocating for salt reduction, weight loss, and increased physical activity. Additionally, on behalf of the Chinese government, China CDC has organized and carried out the construction of national demonstration areas for the comprehensive prevention and control of chronic diseases. As of 2020, 488 national demonstration areas have been established, covering 17.1% of all counties and districts. In these areas, the lifestyle and health literacy of the population and community-based hypertension management measures have been improved. The
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.